CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
15 hedge funds and large institutions have $7.01M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
31% more capital invested
Capital invested by funds: $5.34M → $7.01M (+$1.67M)
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$257K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$155K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$40.4K |
| 4 |
Goldman Sachs
New York
|
+$31.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACI
Alpha Cubed Investments
Irvine,
California
|
-$63K |
| 2 |
SIM
Spark Investment Management
New York
|
-$16.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.58K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.07K |
| 5 |
NPC
National Planning Corporation
El Segundo,
California
|
-$2.14K |
CPXX Hedge Fund Activity: Q1 2015 in Review
15 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q1 2015, worth a combined $7.01M — up 31% from $5.34M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CPXX positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $257K. The largest seller was Alpha Cubed Investments, exiting entirely with an estimated $63K sold.
- 15 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q1 2015, up from 14 in Q4 2014.
- Funds reported $7.01M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q1 2015, up 31% quarter-over-quarter.
- 4 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q1 2015 and 3 closed out, a net change of +1 holder.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q1 2015 was Vanguard Group, an estimated $257K added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q1 2015 was Alpha Cubed Investments, an estimated $63K sold.
Based on aggregated 13F filings for Q1 2015.